Clinical Trials Browser

INDUSTRY × Lymphoma × pegfilgrastim × Clear all

NCT00364468 2017-03-03

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

Phase 2 Completed

Lymphoma, Neutropenia

NCT02805218 2016-06-20

PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy

Phase 4 Completed

Lymphoma

NCT00066092 2008-02-28

Pegfilgrastim PBPC Mobilization Study

Phase 2 Completed

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms